Bull
$310.11
情景价格
$276.690
-5.340 (-1.93%)收盘时
Veeva Systems Inc. provides cloud solutions for the global life sciences industry. The Company offers cloud software, artificial intelligence (AI), data, and business consulting and is designed to meet the needs of its customers and their strategic business functions, from research and development through commercialization. Its product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes and partners across content management, training, quality management, assurance and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud comprises software and analytics solutions. It owns Ostro, a brand engagement platform for life sciences. It also provides Veeva Falcon MLR, an agentic MLR solution.
Veeva Systems is a good buy right now due to its strong recent performance and positive outlook. The current price is $276.69, with an RSI of 76.97 indicating strong momentum. The company reported Q2 earnings with an EPS of $2.35, exceeding expectations, and has raised its fiscal 2027 sales guidance to between $3.682 billion and $3.687 billion, above analyst estimates. The main risk is the high forward P/E ratio of 27.03, suggesting that the stock may be overvalued if growth slows.
Citi
$273
2026-08-28
Citi
2026-08-28
目标价
$273
Truist
$305
2026-08-27
Truist
2026-08-27
目标价
$305
Stifel
$300
2026-08-27
Stifel
2026-08-27
目标价
$300
RBC Capital
$325
2026-08-27
RBC Capital
2026-08-27
目标价
$325
Raymond James
$330
2026-08-27
Raymond James
2026-08-27
目标价
$330
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Veeva Systems Q2 Results Exceed Expectations

Burry's Portfolio Shows Mixed Performance Amid Market Trends

Burry Reduces Veeva Stake but Remains Optimistic

Software Sector Earnings Review and Market Dynamics

Veeva Systems Reports Strong Q2 Results, Boosts Guidance
Veeva Systems Inc. provides cloud solutions for the global life sciences industry. The Company offers cloud software, artificial intelligence (AI), data, and business consulting and is designed to meet the needs of its customers and their strategic business functions, from research and development through commercialization. Its product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes and partners across content management, training, quality management, assurance and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud comprises software and analytics solutions. It owns Ostro, a brand engagement platform for life sciences. It also provides Veeva Falcon MLR, an agentic MLR solution. It operates in the Healthcare sector (SERVICES-PREPACKAGED SOFTWARE industry).
Veeva Systems is a good buy right now due to its strong recent performance and positive outlook. The current price is $276.69, with an RSI of 76.97 indicating strong momentum. The company reported Q2 earnings with an EPS of $2.35, exceeding expectations, and has raised its fiscal 2027 sales guidance to between $3.682 billion and $3.687 billion, above analyst estimates. The main risk is the high forward P/E ratio of 27.03, suggesting that the stock may be overvalued if growth slows.
14 analysts cover VEEV: 8 rate it Buy, 6 Hold and 0 Sell. The average price target is 317.10.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。